What is the appropriate management for a grade 2-3 placenta at 37 weeks gestation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Grade 2-3 Placenta at 37 Weeks Gestation

Critical Clarification

The term "grade 2-3 placenta" refers to placental maturity grading (Grannum classification), which is an outdated ultrasound finding that has no clinical significance and should not guide management decisions. This grading system describes placental calcification patterns but does not predict fetal lung maturity, adverse outcomes, or necessitate any specific intervention.

Appropriate Management Approach

At 37 weeks gestation with a grade 2-3 placenta finding alone, routine prenatal care should continue with delivery planned at 39-40 weeks for an uncomplicated pregnancy. The placental grading itself requires no specific management.

Key Management Principles:

  • Placental grading (Grannum classification) is not used in modern obstetric practice to make clinical decisions about timing of delivery, fetal well-being, or need for intervention
  • Grade 2-3 placental appearance represents normal age-related changes and calcification patterns that occur commonly in term pregnancies
  • This finding does NOT indicate placental insufficiency, fetal compromise, or need for early delivery

What Actually Matters - Rule Out Significant Pathology:

If this patient has concerning clinical features beyond the placental grading, management should be directed by those specific conditions:

If Preeclampsia is Present:

  • Women with preeclampsia at ≥37 weeks' gestation should be delivered 1
  • Delivery is indicated regardless of severity when reaching term gestation 1

If Fetal Growth Restriction with Abnormal Dopplers:

  • Delivery at 37 weeks is recommended for decreased diastolic flow on umbilical artery Doppler 2
  • Earlier delivery at 33-34 weeks for absent end-diastolic velocity or 30-32 weeks for reversed end-diastolic velocity 2

If Placenta Previa:

  • For uncomplicated placenta previa, optimal delivery timing is 38 0/7 to 38 6/7 weeks gestation 3
  • This balances neonatal outcomes with risk of emergent delivery from hemorrhage 3

If Gestational Diabetes:

  • A1GDM (diet-controlled): delivery at 38 weeks 4
  • A2GDM (medication-dependent): delivery by 39 weeks 4

Standard Term Management (No Complications):

  • Continue routine prenatal surveillance
  • Plan delivery at 39-40 weeks gestation for optimal neonatal outcomes
  • No additional fetal surveillance is warranted based solely on placental grading

Common Pitfalls to Avoid:

  • Do not use placental grading to justify early delivery - this outdated practice increases iatrogenic prematurity without benefit
  • Do not order additional testing (biophysical profiles, non-stress tests, Doppler studies) based solely on placental grade
  • Do not counsel patients that placental grading indicates "aging placenta" requiring intervention - this creates unnecessary anxiety

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Timing of Delivery for Fetal Growth Restriction (FGR) with Abnormal Dopplers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Timing of cesarean delivery in women with uncomplicated placenta previa.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2022

Guideline

Timing of Delivery for Gestational Diabetes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.